Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar 3;7(1):68.
doi: 10.1038/s41392-022-00929-9.

Overcoming unintended immunogenicity in immunocompetent mouse models of metastasis: the case of GFP

Affiliations
Comment

Overcoming unintended immunogenicity in immunocompetent mouse models of metastasis: the case of GFP

Christoph Schultheiß et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Unintended immunogenicity of GFP in immunocompetent mouse models of metastasis can be avoided by using models with central tolerance towards GFP. GFP-expressing metastatic 4T1 breast cancer cells form lung metastases after orthotopical transplantation in immunocompromised NOD-SCID mice. In immunocompetent BALB/c mice and a model of peripheral tolerance (Gnrhr-luc/GFP), formation of metastasis is prevented by a GFP-specific CD8+ T cell response independent of GFP expression level. In contrast, GFP-expressing 4T1 cells can form lung metastases while lacking a GFP-directed T cell response in a model of central tolerance towards GFP (Cx3cr1-GFP;CCR2-RFP). Created with BioRender.com

Comment on

References

    1. Grzelak, C. A. et al. Elimination of fluorescent protein immunogenicity permits modeling of metastasis in immune-competent settings. Cancer Cell40,1–2 (2022). 10.1016/j.ccell.2021.11.004. Epub 2021 Dec 2. - PMC - PubMed
    1. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670–691. doi: 10.1016/j.cell.2016.11.037. - DOI - PMC - PubMed
    1. Giacobbe A, Abate-Shen C. Modeling metastasis in mice: a closer look. Trends Cancer. 2021;7:916–929. doi: 10.1016/j.trecan.2021.06.010. - DOI - PMC - PubMed
    1. Day CP, et al. “Glowing head” mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts. PLoS ONE. 2014;9:e109956. doi: 10.1371/journal.pone.0109956. - DOI - PMC - PubMed
    1. Ferdosi SR, et al. Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat. Commun. 2019;10:1842. doi: 10.1038/s41467-019-09693-x. - DOI - PMC - PubMed

Publication types